We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

144 hedge funds and large institutions have $678M invested in Arcturus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 41 increasing their positions, 52 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 11

22% more capital invested

Capital invested by funds: $558M → $678M (+$120M)

16% more funds holding

Funds holding: 124 → 144 (+20)

1.18% more ownership

Funds ownership: 87.8% → 88.98% (+1.2%)

21% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 52

45% less call options, than puts

Call options by funds: $4.75M | Put options by funds: $8.67M

Holders
144
Holders Change
+20
Holders Change %
+16.13%
% of All Funds
2.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
41
Reduced
52
Closed
11
Calls
$4.75M
Puts
$8.67M
Net Calls
-$3.92M
Net Calls Change
-$3.6M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$7.23M
2
WP
Woodline Partners
California
+$6.84M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$5.67M
4
BlackRock
BlackRock
New York
+$5.33M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.44M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$20.8M
2
State Street
State Street
Massachusetts
-$6.91M
3
PM
Prosight Management
Texas
-$6.11M
4
Citadel Advisors
Citadel Advisors
Florida
-$5.25M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$2.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
76
Globeflex Capital
California
$518K +$491K +18,047 New
EGM
77
Engineers Gate Manager
New York
$505K +$197K +7,222 +70%
Jacobs Levy Equity Management
78
Jacobs Levy Equity Management
New Jersey
$494K +$469K +17,238 New
CIM
79
Cambria Investment Management
California
$492K +$467K +17,155 New
UBS Group
80
UBS Group
Switzerland
$488K -$659K -24,204 -59%
ZCM
81
Ziegler Capital Management
Illinois
$482K +$457K +16,800 New
CC
82
Corton Capital
Ontario, Canada
$461K -$88.6K -3,255 -17%
FAM
83
Formidable Asset Management
Ohio
$429K – – –
UBS AM
84
UBS AM
Illinois
$405K – – –
KOC
85
Koss-Olinger Consulting
Florida
$401K – – –
American Century Companies
86
American Century Companies
Missouri
$393K +$373K +13,693 New
TAM
87
Tocqueville Asset Management
New York
$376K -$139K -5,100 -28%
Zurich Cantonal Bank
88
Zurich Cantonal Bank
Switzerland
$367K +$190K +6,988 +121%
TRCT
89
Tower Research Capital (TRC)
New York
$362K +$191K +7,026 +126%
MIM
90
MetLife Investment Management
New Jersey
$354K – – –
GAM
91
Gotham Asset Management
New York
$345K +$327K +12,029 New
Lazard Asset Management
92
Lazard Asset Management
New York
$341K +$71.6K +2,632 +28%
Millennium Management
93
Millennium Management
New York
$337K -$2.49M -91,647 -89%
Commonwealth Equity Services
94
Commonwealth Equity Services
Massachusetts
$331K +$29.9K +1,100 +11%
AIG
95
American International Group
New York
$322K +$1.88K +69 +0.6%
VRS
96
Virginia Retirement Systems
Virginia
$321K +$305K +11,200 New
Invesco
97
Invesco
Georgia
$305K +$20K +734 +7%
Los Angeles Capital Management
98
Los Angeles Capital Management
California
$303K -$47.6K -1,750 -14%
Mitsubishi UFJ Asset Management
99
Mitsubishi UFJ Asset Management
Japan
$294K -$179K -6,581 -39%
Janus Henderson Group
100
Janus Henderson Group
United Kingdom
$290K -$354 -13 -0.1%
2 3
4
5 6

ARCT Hedge Fund Activity: Q2 2023 in Review

144 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q2 2023, worth a combined $678M — up 22% from $558M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ARCT positions and 11 closed out — a net gain of 21 holders — while 41 added to existing stakes and 52 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $7.23M. The largest seller was Bank of America, cutting an estimated $20.8M.

  • 144 institutional investors held Arcturus Therapeutics (ARCT) as of Q2 2023, up from 124 in Q1 2023.
  • Funds reported $678M of Arcturus Therapeutics stock for Q2 2023, up 22% quarter-over-quarter.
  • 32 funds opened new Arcturus Therapeutics positions in Q2 2023 and 11 closed out, a net change of +21 holders.
  • The largest Arcturus Therapeutics buyer in Q2 2023 was Renaissance Technologies, an estimated $7.23M added.
  • The largest Arcturus Therapeutics seller in Q2 2023 was Bank of America, an estimated $20.8M sold.

Based on aggregated 13F filings for Q2 2023.